Global Patent Index - EP 2145001 A2

EP 2145001 A2 20100120 - MIR-15, MIR-26, MIR -31,MIR -145, MIR-147, MIR-188, MIR-215, MIR-216 MIR-331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

Title (en)

MIR-15, MIR-26, MIR -31,MIR -145, MIR-147, MIR-188, MIR-215, MIR-216 MIR-331, MMU-MIR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION

Title (de)

VON MIR-15, MIR-26, MIR -31,MIR -145, MIR-147, MIR-188, MIR-215, MIR-216 MIR-331, MMU-MIR-292-3P REGULIERTE GENE UND STOFFWECHSELWEGE ALS ZIELE FÜR EINEN THERAPEUTISCHEN EINGRIFF

Title (fr)

GÈNES RÉGULÉS MIR-15, MIR-26, MIR -31,MIR -145, MIR-147, MIR-188, MIR-215, MIR-216 MIR-331, MMU-MIR-292-3P ET VOIES DE SIGNALISATION UTILES COMME CIBLES DANS UNE INTERVENTION THÉRAPEUTIQUE

Publication

EP 2145001 A2 20100120 (EN)

Application

EP 07814937 A 20070919

Priority

  • US 2007078952 W 20070919
  • US 82617306 P 20060919
  • US 94835007 P 20070706

Abstract (en)

[origin: WO2008036776A2] The present invention concerns methods and compositions for identifying genes or genetic pathways modulated by miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR- 215, miR-216, miR-331, mmu-miR-292-3p, and using nucleic acid comprising all or part of the miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu- miR-292-3p sequences to modulate a gene or gene pathway, using this profile in assessing the condition of a patient and/or treating the patient with an appropriate miRNA.

IPC 8 full level

C12N 15/11 (2006.01); C12N 15/113 (2010.01)

CPC (source: EP US)

A61P 1/00 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 5/00 (2017.12 - EP); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/10 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 33/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/00 (2017.12 - EP); C12N 15/111 (2013.01 - EP US); C12N 15/113 (2013.01 - EP US); C12N 2310/111 (2013.01 - EP US); C12N 2310/141 (2013.01 - EP US); C12N 2320/12 (2013.01 - EP US)

Citation (search report)

See references of WO 2008036776A2

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2008036776 A2 20080327; WO 2008036776 A3 20100318; AU 2007299748 A1 20080327; CA 2663962 A1 20080327; EP 2145001 A2 20100120; IL 197692 A0 20110801; JP 2010510964 A 20100408; US 2009131356 A1 20090521

DOCDB simple family (application)

US 2007078952 W 20070919; AU 2007299748 A 20070919; CA 2663962 A 20070919; EP 07814937 A 20070919; IL 19769209 A 20090319; JP 2009529378 A 20070919; US 16749208 A 20080703